Evolutionary dynamics of residual disease in human glioblastoma

2019-03-01
Spiteri, I.
Caravagna, G.
Cresswell, G. D.
Vatsiou, A.
Nichol, D.
Acar, Ahmet
Ermini, L.
Chkhaidze, K.
Werner, B.
Mair, R.
Brognaro, E.
Verhaak, R. G. W.
Sanguinetti, G.
Piccirillo, S. G. M.
Watts, C.
Sottoriva, A.
Background Glioblastoma is the most common and aggressive adult brain malignancy against which conventional surgery and chemoradiation provide limited benefit. Even when a good treatment response is obtained, recurrence inevitably occurs either locally (approximate to 80%) or distally (approximate to 20%), driven by cancer clones that are often genomically distinct from those in the primary tumour. Glioblastoma cells display a characteristic infiltrative phenotype, invading the surrounding tissue and often spreading across the whole brain. Cancer cells responsible for relapse can reside in two compartments of residual disease that are left behind after treatment: the infiltrated normal brain parenchyma and the sub-ventricular zone. However, these two sources of residual disease in glioblastoma are understudied because of the difficulty in sampling these regions during surgery.
Citation Formats
I. Spiteri et al., “Evolutionary dynamics of residual disease in human glioblastoma,” pp. 456–463, 2019, Accessed: 00, 2021. [Online]. Available: https://hdl.handle.net/11511/89495.